Global Gateway for Life Sciences
Global Life Sciences Gateway · Section 04 — External Experts Boston / Cambridge · Korea · Europe

Section 04 · About GLSG

World-Class Advisors for Your Global Expansion

Abstract

Partner with seasoned bio-pharma executives and clinical leaders who possess a proven track record of driving cross-border success.

4.1 — External Expert

Pascal Borderies, MD

New York: CMO, Clinical Drug Development, Immuno-Oncology

Pascal Borderies, MD, is an accomplished Chief Medical Officer & biopharma executive with a deep expertise in clinical development strategy & execution for early clinical compounds in various therapeutic areas — including but not limited to neurodegenerative diseases, autoimmune diseases, immuno-oncology — discerning the key questions that need to be answered to maximize their value in the marketplace. He has held key leadership roles in small biotechs & global pharmaceutical leaders, including Novartis and Sanofi.

4.2 — External Expert

Jean-Luc Boulnois, PhD

Boston: Medical Device, Medtech Executive

Dr. Jean-Luc Boulnois is a 38-year medical device industry veteran who scaled global medtech companies like Microline Surgical, currently serving as President & CEO of Quadrature Inc., where he leverages an extensive international healthcare network to provide strategic and operational expertise to early-stage entrepreneurs and mid-market CEOs.

4.3 — External Expert

Eric Evans

Boston: Investor, Executive Committee, Mass Medical Angels

Eric Evans is an early-stage investor in life sciences companies with over 24 years of experience in business growth consulting and executive leadership. He serves on the Executive Committee at Mass Medical Angels, where he leads financing rounds and performs due diligence. Throughout his career, he has frequently stepped into leadership roles as an interim CEO or Board member to accelerate early-stage healthcare companies toward advanced development.

4.4 — External Expert

David S. Friedman, MD, PhD, MPH

Boston: Glaucoma Specialist, Clinical Research

David S. Friedman, MD, PhD, MPH is a glaucoma specialist and epidemiologist with over 450 publications and over 25 years of clinical experience. He has had consistent federal grant funding throughout his highly successful career and brings a wealth of knowledge to the team about the conduct of clinical research and the clinical landscape.

4.5 — External Expert

Silvia Helou, MD, PhD, MMSc

New York: Clinical Trial, Medical Device

Dr. Silvia Helou is a global clinical development expert with over 25 years of experience in infectious diseases and multiple therapeutics areas, who has driven multiple successful FDA approvals and global Phase I–IV trials at major pharma leaders like Novartis and Schering-Plough, and currently provides strategic clinical consulting as the Founder of Helou Consulting.

4.6 — External Expert

Mac M. Martirossian

Atlanta: Investment Banking, Corporate Finance, M&A Advisory

Mac M. Martirossian is an accomplished business executive and financial strategist with extensive experience in corporate finance, investment banking, and strategic planning. A Certified Public Accountant, he has held senior management roles at The Home Depot and worked as a consultant and auditor with Price Waterhouse. He specializes in mergers and acquisitions, cross-functional leadership, and executive coaching, helping companies scale across international markets.

4.7 — External Expert

Jean-Marie P. Vallet, PhD

Boston: Investor, Business Executive, Business Development, M&A

Dr. Jean-Marie P. Vallet is a scientist and a business executive with international experience in technology evaluation, business development, and consulting. A former molecular biology engineer (PhD) with 10 years of experience in contract research organizations, he transitioned to business executive roles (after an MBA) in both large pharma and small biotechs across four countries (France, Switzerland, Germany, USA). He focuses on international sales and administration, business development, M&A, and consulting. He also brings 10 years of experience as an angel investor within the Boston innovation ecosystem, supporting and advising early-stage startups.

The experts are listed in alphabetical order.

World-class expertise for cross-border success.

Reach out to GLSG for tailored biotech guidance.